US2005214791A1PendingUtilityA1
Mammalian secreted proteins
Est. expiryJun 30, 2020(expired)· nominal 20-yr term from priority
C07K 14/52C07K 2319/00C07K 14/47
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides to polynucleotides and secreted proteins encoded by the polynucleotides. The proteins include a variety of fusion proteins, including fusions comprising a signal peptide selected from the group consisting of signal peptides shown in SEQ ID NO:M, wherein M is an even integer from 2 to 328, operably linked to a second polypeptide. The invention further provides therapeutic and diagnostic methods utilizing the polynucleotides, polypeptides, and antagonists of the polypeptides.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide comprising fifteen contiguous amino acid residues of a polypeptide as shown in SEQ ID NO:M, wherein M is an even integer from 2 to 328.
2 . The isolated polypeptide of claim 1 which is from 15 to 723 amino acid residues in length.
3 . The isolated polypeptide of claim 2 , wherein said at least fifteen contiguous amino acid residues of SEQ ID NO:M are operably linked via a peptide bond or polypeptide linker to a second polypeptide selected from the group consisting of maltose binding protein, an immunoglobulin constant region, a polyhistidine tag, and a peptide as shown in SEQ ID NO:329.
4 . The isolated polypeptide of claim 1 comprising at least 30 contiguous residues of SEQ ID NO:M.
5 . The isolated polypeptide of claim 1 comprising at least 47 contiguous residues of SEQ ID NO:M.
6 . The isolated polypeptide of claim 1 wherein the polypeptide comprises the mature protein encoded by SEQ ID NO:N, wherein N is an odd integer from 1 to 327.
7 . The isolated polypeptide of claim 1 wherein the polypeptide comprises the full-length polypeptide encoded by SEQ ID NO:N, wherein N is an odd integer from 1 to 327.
8 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment encoding the polypeptide of claim 1; and a transcription terminator.
9 . A cultured cell comprising the expression vector of claim 8 .
10 . A method of producing a polypeptide comprising culturing the cell of claim 9 under conditions whereby said sequence of nucleotides is expressed, and recovering said polypeptide.
11 . A polypeptide produced by the method of claim 10 .
12 . An isolated polynucleotide encoding a fusion protein, said protein comprising a secretory peptide selected from the group consisting of secretory peptides shown in Table 1, operably linked to a second polypeptide.
13 . An expression vector comprising the following operably linked elements:
a transcription promoter; a DNA segment encoding fusion protein, said protein comprising a secretory peptide selected from the group consisting of secretory peptides shown in Table 1, wherein M is an even integer from 2 to 328, operably linked to a second polypeptide; and a transcription terminator.
14 . A cultured cell comprising the expression vector of claim 13 , wherein the cell expresses the DNA segment and produces the encoded fusion protein.
15 . A method of producing a protein comprising culturing the cell of claim 14 under conditions whereby said DNA segment is expressed, and recovering said second polypeptide.
16 . An antibody that specifically binds to a protein selected from of the group consisting of SEQ ID NO:M, wherein M is an even integer from 2 to 328.
17 . An isolated polypeptide comprising fourteen contiguous amino acid residues of a polypeptide as shown in SEQ ID NO:M, wherein M is an even integer from 2 to 328.
18 . A method of detecting protein secretion from a cell or tissue comprising detecting a mature MSP selected from the group consisting of SEQ ID NO:M, wherein M is an even integer from 2 to 328 in conditioned media or membrane extracts.Join the waitlist — get patent alerts
Track US2005214791A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.